Immunogenicity and reactogenicity of heterologous prime-boost vaccination with inactivated COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccines, a quasi-experimental study

The global supply of COVID-19 vaccines has been limited, and concerns have arisen about vaccine supply chain disruptions in developing countries. Heterologous prime-boost vaccination, which involves using different vaccines for the first and second doses, has been proposed to enhance the immune resp...

Descripción completa

Detalles Bibliográficos
Autores principales: Tawinprai, Kriangkrai, Jungsomsri, Pawornrath, Pinijnai, Onnicha, Tavonvunchai, Fahsiri, Lievjaroen, Anchisa, Suwannaroj, Paphada, Siripongboonsitti, Taweegrit, Porntharukchareon, Thachanun, Sornsamdang, Gaidganok, Ungtrakul, Teerapat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Coronavirus
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294770/
https://www.ncbi.nlm.nih.gov/pubmed/37140889
http://dx.doi.org/10.1080/21645515.2023.2206360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294770/
https://www.ncbi.nlm.nih.gov/pubmed/37140889
http://dx.doi.org/10.1080/21645515.2023.2206360

Ejemplares similares